In addition, it has been found that the immunological effects of low levels of IL-27 in MS patients with psoriasis comorbidity have been suggested to be mitigated by the reverse impact of high levels of IL-27 generated by psoriasis51. This evidence concerns the gene IL27 and myeloid sarcoma.